uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Randomized Trials of Systemic Medically-treated Malignant Mesothelioma: A Systematic Review
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Medicinska och farmaceutiska vetenskapsområdet, centrumbildningar mm, Centre for Research and Development, Gävleborg.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Medicinska och farmaceutiska vetenskapsområdet, centrumbildningar mm, Centre for Research and Development, Gävleborg.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Medicinska och farmaceutiska vetenskapsområdet, centrumbildningar mm, Centre for Research and Development, Gävleborg. Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Radiology, Oncology and Radiation Science.
Show others and affiliations
2015 (English)In: Anticancer Research, ISSN 0250-7005, E-ISSN 1791-7530, Vol. 35, no 5, 2493-2501 p.Article, review/survey (Refereed) Published
Abstract [en]

Malignant pleural mesothelioma (MPM) is a rare but aggressive malignancy mainly localized to the pleura. Malignant mesothelioma grows highly invasive into surrounding tissue and has a low tendency to metastasize. The median overall survival (OS) of locally advanced or metastatic disease without treatment is 4-13 months but, during recent years, improvement in survival has been achieved since treatment for patients with mesothelioma has improved with better palliative care, systemic medical treatment, surgery and improved diagnostics methods. The present review aims at describing available data from randomized trials considering systemic medical treatment for this patient category.

Place, publisher, year, edition, pages
2015. Vol. 35, no 5, 2493-2501 p.
Keyword [en]
Malignant mesothelioma, randomized trials, review
National Category
Cancer and Oncology
Identifiers
URN: urn:nbn:se:uu:diva-257356ISI: 000354267200003OAI: oai:DiVA.org:uu-257356DiVA: diva2:839572
Available from: 2015-07-03 Created: 2015-07-01 Last updated: 2017-12-04Bibliographically approved

Open Access in DiVA

No full text

Authority records BETA

Holgersson, GeorgBergqvist, MichaelAdwall, LindaEkman, SimonBergström, Stefan

Search in DiVA

By author/editor
Holgersson, GeorgBergqvist, MichaelAdwall, LindaEkman, SimonBergström, Stefan
By organisation
Centre for Research and Development, GävleborgDepartment of Radiology, Oncology and Radiation ScienceEndocrine SurgeryExperimental and Clinical OncologyDepartment of Immunology, Genetics and Pathology
In the same journal
Anticancer Research
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 570 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf